Cardlytics Continues Income Contraction Amidst Deterioration Business Economics (NASDAQ: CDLX)

.Financial article writer advises selling Cardlytics, Inc. due to dropping device business economics, income difficulties, and damaging economic patterns. Click on for this CDLX improve.